By analyzing multiple SAGE (Serial Analysis of Gene Expression) databases containing both cancerous and normal tissues, investigators found that MSLN was specifically upregulated in approximately 50% of ovarian cancer cases, and this percentage was significantly higher than that of normal ovarian tissues.36 Here, MSLN is linked to ovarian cancer.